Introduction: Available data suggest that there is an association between endometriosis and a group of disorders including autonomic nervous system irregularities. A deeper understanding of relationship between endometriosis and autonomic nervous system is needed as it may lead to novel discoveries on the causes or consequences of endometriosis. In this study, we analyzed the prevalence of migraine in patients with endometriosis. Methods: In this cross-sectional study, medical records of women were reviewed through January 2013 to December 2017. Women with laparoscopically proven endometriosis (n = 185) were compared with those without endometriosis (n = 168). The 3-item screening questions (ID Migraine™) test was used to screen migraine. Data were analyzed using SPSS v25 (IBM Corporation). The χ 2 test was used for analyzing the nominal parameters and group comparisons. Pearson χ 2 was used to study the association between endometriosis and migraine. Results: The mean age was 31.86 ± 4.49 years of the endometriosis group and 28.95 ± 5.11 years of the controls (p = 0.408). The two pre-screening questions of ID Migraine test were answered positively by 86 patients of the endometriosis group (75.4%) and by 53 patients of the control group (54.6%) (p = 0.001). Of these patients, 51 (44.7% of endometriosis group) and 26 (26.8% of control group) were diagnosed as having migraine using 3-item Migraine questionnaire (p = 0.007).
Introduction
Endometriosis is a common health problem in women. The prevalence of endometriosis in the general population is estimated to be 7%-10%. 1, 2 It still remains an enigmatic disorder in that the cause and the precise mechanisms by which it causes pain are not completely understood. There is evidence that women with endometriosis may represent a high-risk group for a number of diseases such as cancer, autoimmune diseases, asthma or allergic manifestations, and cardiovascular diseases. [2] [3] [4] [5] There is also association between autonomic nervous system disorders and pain syndromes. 6, 7 A number of studies showed that women with endometriosis are more likely to suffer headache and migraine than those without endometriosis. 3 Increased pain sensitivity induced by one of the disorders may lead to a higher likelihood of developing the other. For physicians dealing with women with either of these disorders, awareness of the comorbidity may be helpful in the treatment of the patients.
Headache and endometriosis show some similarities in their clinical and epidemiological features. Headache as an axillary symptom may even worsen the quality of life in women with endometriosis. Migraine is a chronic condition that affects an estimated 18% of women. The highest prevalence is in those women in 18-49 years of age, generally when women menstruate. 8 Migraine is diagnosed in less than half of patients and is more likely to be neglected in those with comorbid illnesses. [9] [10] [11] One of the reasons is that specialists are used to focus to the diseases related to their main interest. The International Classification of Headache Disorders (Second Edition) states that a headache should meet seven criteria and physicians should ask at least nine questions to establish a diagnosis of migraine without aura. 12 It is crucial to take a full and detailed medical history before starting the gynecologic examination. Patients with endometriosis-associated pain must be questioned for comorbidities also.
Correct workup and diagnosis in patients with endometriosis and pelvic pain are crucial because inappropriate treatment can result in inadequate pain relief and poor patient outcomes. Because the underlying mechanisms of the relationship between endometriosis and comorbidities are not known, a deeper understanding is needed as it may lead to novel discoveries on the causes or consequences of endometriosis. Moreover, treatment of endometriosis can be more individualized and modified according to accompanying comorbidities. Lipton et al. 13 developed a simple set of questions to screen migraine in patients with severe and frequent headaches. In this study, we used the ID Migraine™ questionnaire developed by Lipton et al. to determine the prevalence of migraine as an autonomic nervous system disorder in patients with endometriosis.
Materials and methods
This cross-sectional study was performed at Istanbul University, Istanbul Medical School, Department of Obstetrics and Gynecology, Reproductive Endocrinology and Infertility Unit. The study is approved by ethical committee of Istanbul University, Istanbul Medical School. Medical records of all women admitted to our unit between January 2013 and December 2017 were reviewed. Demographic data are obtained from medical files of the patients. Women who were not capable to communicate, unwilling to enter the study, and younger than 18 years of age were excluded. The number of the patients and controls needed were calculated before starting to the study. The eligible patients were interviewed by the telephone about structured questionnaire designed for this study. Women who have laparoscopically proven endometriosis (n = 185) formed the study group. We randomly selected 168 infertile patients as our control group. These women were pain free and not diagnosed as endometriosis during routine workup. First, verbal informed consent is obtained from the participants. The 3-item screening questions, ID Migraine test (previously validated for Turkish, linguistically), which has 91.8% sensitivity, 63.4% specificity, 71.9% positive predictive value, and 88.4% negative predictive value, is used for screening migraine. 14 If the patient had two or more headaches during the past 3 months, two pre-test questions of the ID Migraine test were introduced: (1) Do your headaches limit your ability to work, study, or enjoy life? (2) Do you want to talk to your healthcare professional about your headaches? If they answered "yes" to at least one of these pre-test questions, the three screening questions for migraine were applied:
1. Did you feel nauseated or sick to your stomach with your headaches? 2. Did light bother you when you had a headache (a lot more than when you do not have headaches)? 3. Did your headache limit your ability to work, study, or do what you needed to do for at least 1 day?
The cut-off point for a test diagnosis of migraine was at least two positive responses. The test positive women were also asked whether their headaches were related to menstruation to find out the prevalence of menstrual migraine.
Statistical analyses
Data were analyzed using SPSS v25 (IBM Corporation). The χ 2 test was used for analyzing the nominal parameters. The continuous variables were expressed as either median (minimum-maximum) or mean (standard deviation (SD)). A p value of <0.05 was considered significant. Group comparisons were performed using the χ 2 test. Pearson χ 2 was used to study the association between endometriosis headache and migraine.
Results
Our study group (laparoscopically proven infertile, endometriosis patients) includes 185 patients, whereas our control group (infertile patients without endometriosis) includes 168 patients. We reached 116 of women with endometriosis and 98 of women from the control group. The mean age was 31.86 ± 4.49 (min: 21, max: 42) years of the endometriosis group and 28.95 ± 5.11 (min: 20, max: 44) years of the control group; the difference was not statistically significant (p = 0.408). Two women from endometriosis group and one woman from control group refused to participate to the study. In all, 109 women of the endometriosis group (96%) and 75 women (77%) from the control group had two or more headaches during the past 3 months. The two pre-screening questions of the test were answered positively by 86 patients of the endometriosis group (75.4%) and by 53 patients of the control group (54.6%); the difference was statistically significant (p = 0.001). Of these patients, 51 (44.7% of endometriosis group) and 26 (26.8% of control group) were diagnosed with migraine by the 3-item Migraine questionnaire; the difference was statistically significant (p = 0.007). The prevalence of menstrual migraine was 45.1% in the endometriosis group (23/51) and 30.8% in the control group (8/26); the difference was not statistically significant (p = 0.275). The prevalence of nonmigraine-type headaches was also very high; 35 of the endometriosis group (35/114, 30.7%) and 27 of the control group (27/98, 27.84%) were suffering from nonmigraine-type headaches (p = 0.65). The results of the questionnaire are summarized in Figure 1 . In endometriosis group, 35% of the women have been using an oral contraceptive pill (OCP). However, only 3% of the controls were on OCP. The difference was statistically significant (p < 0.001).
Discussion
Several studies have supported a relationship between endometriosis, headache, and migraines. 3, 15, 16 Probably, the influence of female sex hormones on both disorders and increased pain sensitivity induced by one of the disorders may lead to developing the other. Headache and endometriosis show some similarities in epidemiological features. Some common molecular mechanisms were proposed to explain the association of endometriosis and migraine. It has been postulated that IFN-γ gene polymorphism may contribute to susceptibility to migraine and pelvic pain in women with endometriosis by increasing the amount of neuropeptide calcitonin gene-related peptide (CGRP) through mitogen-activated protein kinase (MAPK) signaling pathways. 17 However, the nature of this association still remains unclear.
In this study, we investigated the prevalence of headache and migraine in patients with endometriosis using ID Migraine questionnaire. The results of validated versions of ID Migraine test worldwide are very similar (Table 1) . In this study, we used the test validated for Turkish. Our results showed that ID Migraine questionnaire test was significantly more positive in patients with endometriosis. Although it is not significant, nonmigraine-type headache was also more frequent in patients with endometriosis. In our study, percentage of patients with endometriosis who use OCPs was much higher compared to control. Therefore, one could hypothesize that the comorbidity may be due to use of these compounds. However, despite the positive epidemiological association between OCP use and migraine, there may not be a direct causal link. Theoretically, estrogens such as during the pill-free interval of combined oral contraceptives can induce headache and/or migraine. Although relationship between OCP use and migraine is still controversial, [23] [24] [25] [26] we still need to clarify the question whether the higher use of OCPs in endometriosis group cause a higher incidence of migraine. Our data showed that the prevalence of menstrual migraine was 45.1% in the endometriosis group (23/51) and 30.8% in the control group (8/26) . The difference between the study and control groups was not statistically significant (p = 0.275). So, menstrual migraine is not dominated in women in the study group, meaning that OCP use has no effect on the prevalence of migraine in patients with endometriosis. Moreover, current data show that extended OCP regimen reduces menstrual migraine severity. 27 In a population-based cohort study, the prevalence of migraine was analyzed. This study showed that patients with endometriosis were more likely to suffer migraine headaches compared to controls. In addition, the comorbid association between migraine and endometriosis remained significant after the data were controlled for frequently utilized hormone therapies. The results of this cohort study support the existence of a comorbid relationship between migraine and endometriosis, even after adjusting for the possible effects of female hormone therapies on migraine attacks. 15 Our findings are consistent with this study. Karp et al. 28 examined the prevalence of migraine in women with chronic pelvic pain with and without endometriosis. They show that regardless of endometriosis migraine is highly associated with chronic pelvic pain. In our study, we did not compare the presence or severity of the pain in patients with endometriosis and existence of migraine. However, we still find a significant association in these two conditions. Studying the relationship between severity of chronic pelvic pain and migraine as a comorbidity would give us more information about the pathophysiology of these condition. Tietjen et al. 29 studied the characteristics of headache in women with migraine and endometriosis and differences in the prevalence of comorbid conditions between female migraineurs with and without endometriosis. They found that prevalence of endometriosis is higher in women with migraine. Our findings are also consistent with them. They conclude that migraineurs with endometriosis have more frequent and disabling headaches and are more likely to have other comorbid conditions affecting mood and pain. These studies together lead necessity of gathering information about headache and migraine in patients with endometriosis. In a cross-sectional study conducted within the Women's Health Study, migraine diagnosis was self-reported. Adolescents with endometriosis were more likely to experience migraines (69.3%) than those without endometriosis (30.7%), 30 and participants with endometriosis and migraines had more dysmenorrhea than those without migraines. 24 The authors conclude that due to the strong correlation, patients who present with either condition should be screened for comorbidity to maximize the benefits of care.
In our settings, patients in endometriosis group were simply compared with the controls, and association of pelvic pain was not analyzed. Using a questionnaire to make the diagnosis for migraine can also be questioned as a limitation of our study. Straightforward, face-to-face verbal interview with a neurologist is the gold standard for diagnosis migraine. The ID Migraine is not to be used for diagnosis of migraine, but as a risk assessment for this disease.
However, there are similarities between the results of face-to-face interview and screening questionnaires in migraine studies. ID Migraine test is a valid, reliable, and quick screening tool with a very high sensitivity. The possibility of not having migraine is very high if the test is negative. So, the ID Migraine is useful for ruling out rather than ruling in migraine. The ID Migraine test is easy to use and takes only a few minutes to answer. Gynecologist can make a quick assessment of headache by asking two short and simple pre-test questions of ID Migraine test. Knowledge and use of a linguistically validated ID Migraine test cause early diagnosis of endometriosis-associated headache and migraine. 
Conclusion
This study showed that the prevalence of an autonomic nervous system disorder, migraine, was significantly higher in patients with endometriosis compared to infertile controls. Although our results were consistent with the current literature, limitations of this study must be taken into account. Headache should be evaluated in all patients with endometriosis because of its high prevalence and impact. One can make a quick assessment about headache and migraine in patients with endometriosis using ID Migraine test. This will increase the efficacy of treatment for pain and improve the health quality of the patient. Treatment of endometriosis can be individualized and modified according to comorbidities.
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